" /> Ribociclib - CISMeF





Preferred Label : Ribociclib;

NCIt synonyms : 7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide;

NCIt definition : An orally available cyclin-dependent kinase (CDK) inhibitor targets at cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. Ribociclib specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation.;

UNII : TK8ERE8P56;

InChIKey : RHXHGRAEPCAFML-UHFFFAOYSA-N;

CAS number : 1211441-98-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1211441-98-3 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Kisqali;

Molecule name : LEE-011;

Codes from synonyms : 441;

Details


You can consult :


Nous contacter.
08/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.